2026世界（欧洲）疫苗大会WVC

The 2026 World Vaccine Congress Europe (WVC Europe) is one of the most influential and largest annual events in the global vaccine research, development, production, and commercialization sectors. With a long history, as an important part of the World Vaccine Congress series, it is held annually in a major European city, attracting top vaccine scientists, researchers, clinicians, public health experts, pharmaceutical executives, regulatory representatives, and investors from around the world. WVC Europe is not only a platform for showcasing the latest scientific achievements and technological breakthroughs but also a crucial hub for promoting industry exchange, policy formulation, and business cooperation. The congress typically brings together over 200 exhibitors, including leading global vaccine manufacturers, biotechnology companies, contract research organizations (CROs), diagnostic companies, equipment suppliers, vaccine adjuvant, and delivery system developers. They showcase the latest vaccine products, R&D pipelines, innovative technologies, and solutions. At the same time, the congress attracts thousands of professional visitors from around the world, including decision-makers and technical experts from large pharmaceutical companies, small and medium-sized biotechnology enterprises, academic institutions, government departments, and non-governmental organizations. These exhibitors and visitors collectively form the most active ecosystem in the vaccine industry, driving progress in vaccine science and the development of global public health. WVC Europe is renowned for its high-quality scientific agenda, typically featuring multiple parallel sessions covering various stages of vaccine R&D, from basic research to clinical trials, and then to manufacturing process optimization and market access strategies. The congress also pays special attention to emerging vaccine technologies, such as mRNA vaccines, viral vector vaccines, protein subunit vaccines, etc., as well as innovative vaccine strategies for infectious diseases (e.g., influenza, COVID-19, HIV, tuberculosis, malaria, etc.) and non-communicable diseases (e.g., cancer, autoimmune diseases). In addition, the congress features dedicated innovation zones and startup pitch sessions, providing opportunities for emerging technologies and companies to showcase and secure funding, further solidifying its position as a leading global vaccine conference.

The exhibit range of the 2026 World Vaccine Congress Europe covers the entire industry chain of vaccine research, development, production, testing, distribution, and related services, aiming to showcase the latest scientific breakthroughs, technological innovations, and commercial solutions. Key exhibit categories and specific exhibits include: 1. **Vaccine Products and R&D Pipelines**: - **Various Vaccines**: For infectious diseases (e.g., influenza vaccines, COVID-19 vaccines, hepatitis B vaccines, HPV vaccines, MMR vaccines, pneumonia vaccines, rabies vaccines, tuberculosis vaccines, malaria vaccines, HIV vaccines, etc.) and non-communicable diseases (e.g., cancer vaccines, autoimmune disease vaccines, allergy vaccines, etc.). - **Emerging Vaccine Technologies**: mRNA vaccines, DNA vaccines, viral vector vaccines (e.g., adenovirus vectors, poxvirus vectors), protein subunit vaccines, peptide vaccines, conjugate vaccines, live vector vaccines, inactivated vaccines, etc. - **Novel Adjuvants and Delivery Systems**: Various vaccine adjuvants (e.g., aluminum adjuvants, emulsion adjuvants, TLR agonists), nanoparticle delivery systems, microneedle delivery systems, oral vaccine delivery technologies, etc. 2. **Vaccine R&D and Preclinical/Clinical Trial Services**: - **Contract Research Organizations (CROs)**: Providing preclinical research, toxicology studies, pharmacokinetic studies, all phases of clinical trials (Phase I/II/III), biostatistics, data management, medical writing, and other services. - **Biomarkers and Diagnostics**: Vaccine immunogenicity assessment, antibody detection, cellular immunity detection, biomarker discovery and validation, companion diagnostic products. - **Animal Models**: Various animal models and related services for vaccine efficacy and safety evaluation. 3. **Vaccine Production Equipment and Technology**: - **Bioreactors and Fermenters**: Single-use bioreactors, stainless steel bioreactors, cell culture and fermentation systems. - **Purification and Separation Equipment**: Chromatography systems, ultrafiltration/microfiltration systems, centrifuges, depth filtration systems. - **Filling and Packaging Equipment**: Aseptic filling machines, lyophilizers, vial/pre-filled syringe filling lines, labeling machines, packaging machines. - **Culture Media and Reagents**: Serum-free culture media, cell culture additives, biopharmaceutical-grade reagents, buffers. - **Quality Control and Testing Equipment**: HPLC, mass spectrometers, PCR machines, ELISA readers, cell counters, microbiological testing systems. - **Sterile and Cleanroom Technologies**: Cleanroom equipment, laminar flow hoods, isolators, biosafety cabinets, sterilization equipment. 4. **Vaccine Supply Chain and Cold Chain Logistics**: - **Cold Chain Storage and Transport Solutions**: Medical refrigerators, cold boxes, cold chain monitoring systems, temperature data loggers, specialized cold chain logistics services. - **Vaccine Distribution and Management Systems**: Inventory management software, traceability systems, anti-counterfeiting technologies. 5. **Policy, Regulation, Market Access, and Investment**: - **Regulatory Consulting Services**: FDA/EMA/CFDA and other regulatory agency submission consulting, GMP compliance consulting, quality system establishment. - **Market Analysis and Business Intelligence**: Vaccine market reports, competitive intelligence, business strategy consulting. - **Intellectual Property and Legal Services**: Patent application and protection, technology licensing, legal consulting. - **Venture Capital and Funds**: Venture capital firms, private equity funds, and incubators specializing in biopharmaceuticals and vaccines.

No fee information available. Please contact us for a quote.